Evidence map›Paper›PMID 40693643›Full record

ArticleJournal of oral rehabilitation2025

Does the Dental Formula Predict Therapy Outcomes of Obstructive Sleep Apnoea Treated With a Mandibular Advancement Device ? A Retrospective Cross-Sectional Study.

Constance Cuny, Philippe Kemoun, Florent Destruhaut, Coraline Sipra, Mathieu Marty, Delphine Comtesse-Maret, Frédéric Vaysse

Abstract read
In one paragraph

Article in Journal of oral rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Mandibular advancement devices in obstructive sleep apnea: diagnostic predictors for treatment response and clinical implications : A retrospective pilot cohort study.Journal of orofacial orthopedics = Fortschritte der Kieferorthopadie : Organ/official journal Deutsche Gesellschaft fur Kieferorthopadie · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Constance CunyLaboratoire Centre d'Anthropobiologie et de Génomique de Toulouse, Université Paul Sabatier, Toulouse, France.ORCID https://orcid.org/0009-0000-7945-757X
Philippe KemounHealth Faculty-Dentistry Department, Toulouse Institute of Oral Medicine and Science, CHU de Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0001-7373-2657
Florent DestruhautHealth Faculty-Dentistry Department, Toulouse Institute of Oral Medicine and Science, CHU de Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0002-1011-2212
Coraline SipraHealth Faculty-Dentistry Department, Toulouse Institute of Oral Medicine and Science, CHU de Toulouse, Toulouse, France.
Mathieu MartyHealth Faculty-Dentistry Department, Toulouse Institute of Oral Medicine and Science, CHU de Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0003-0579-341X
Delphine Comtesse-MaretLaboratoire Centre d'Anthropobiologie et de Génomique de Toulouse, Université Paul Sabatier, Toulouse, France.ORCID https://orcid.org/0000-0002-0727-7745
Frédéric VaysseLaboratoire Centre d'Anthropobiologie et de Génomique de Toulouse, Université Paul Sabatier, Toulouse, France.ORCID https://orcid.org/0009-0001-3229-7932

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectivesObstructive sleep apnoea (OSA) is a prevalent sleep disorder with significant health implications. While complete edentulism has been associated with an increased OSA risk, the relationship with partial edentulism remains unclear. This study aimed to investigate the role of dental formula in OSA severity and mandibular advancement device (MAD) therapy outcomes.

methodsA retrospective study initially included 560 patients diagnosed with OSA by polysomnography (PSG). A subset of 75 patients was selected for analysis based on predefined inclusion criteria. Dental parameters were assessed using baseline orthopantomograms. Objective treatment outcomes were evaluated using baseline PSG and repeat PSG with MAD after 3 months of therapy. Differences in OSA severity and MAD treatment outcomes were analysed, and dental parameters were correlated between groups.

resultsThe median baseline apnoea-hypopnoea index (AHI) significantly reduced from 27.82 ± 16.77 to 15.51 ± 13.33 following MAD therapy. Partial edentulism parameters did not differ significantly or correlate with baseline OSA severity. However, a correlation was observed between the number of missing teeth and reassessed AHI (rAHI), and an inverse correlation between the masticatory coefficient and rAHI was also noted. Mandibular edentulism-primarily unilateral or bilateral posterior-was positively correlated with MAD treatment outcomes.

conclusionThis study demonstrates a correlation between edentulism parameters and MAD treatment outcomes in patients with OSA. Collaboration between dentists and sleep medicine specialists is crucial for comprehensive OSA management, including oral health assessment.

trial registrationAfter evaluation and validation by the data protection officer and according to the General Data Protection Regulation, this study met all the criteria and was registered in the register of data study of the Toulouse University Hospital (Register Number: RnIPH 2023-81) and covered by the MR-004 (CNIL Number: 2206723 v 0). This study was approved by Toulouse University Hospital and confirmed that ethical requirements were fully met in the above report.

Indexed as

Mandibular AdvancementSleep Apnea, ObstructiveAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedPolysomnographyRadiography, PanoramicRetrospective StudiesSeverity of Illness IndexTreatment Outcomemandibular advancement devicemasticatory coefficientobstructive sleep apnoeapartial edentulousness

Identifiers

PMID40693643
PMCPMC12515995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.